Analyst Reco. Medpace Holdings, Inc.

Equities

MEDP

US58506Q1094

Real-time Estimate Cboe BZX Other stock markets 10:28:11 2024-07-10 am EDT			5-day change	1st Jan Change
414.4 ^USD	+0.83%		+2.67%	+35.01%

Jul. 08	Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating	MT
Jul. 03	Medpace Holdings, Inc. Announces Board and Committee Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating	Jul. 08	MT
Medpace Holdings Insider Sold Shares Worth $3,081,617, According to a Recent SEC Filing	Jun. 07	MT
Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing	May. 29	MT
TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target	May. 29	MT
Mizuho Starts Medpace Holdings With Buy Rating, $435 Price Target	May. 28	MT
Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing	May. 22	MT
Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing	May. 17	MT
Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing	May. 14	MT
Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing	May. 08	MT
Medpace Holdings Insider Sold Shares Worth $6,553,671, According to a Recent SEC Filing	May. 03	MT
Medpace Holdings Insider Sold Shares Worth $6,782,987, According to a Recent SEC Filing	May. 01	MT
Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating	Apr. 24	MT
Jefferies Upgrades Medpace Holdings to Buy, Price Target at $450	Apr. 23	MT
Deutsche Bank Initiates Coverage on Medpace With Hold Rating, $395 Price Target	Mar. 18	MT
UBS Adjusts Medpace Price Target to $480 From $452, Maintains Buy Rating	Mar. 08	MT
UBS Upgrades Medpace to Buy From Neutral, Adjusts Price Target to $452 From $282	Feb. 15	MT
UBS Adjusts Medpace Price Target to $282 From $270, Maintains Neutral Rating	23-10-25	MT
Baird Upgrades Medpace Holdings to Outperform From Neutral, Adjusts Price Target to $289 From $270	23-10-24	MT
UBS Adjusts Medpace Price Target to $270 From $215, Maintains Neutral Rating	23-07-26	MT
Guggenheim Raises Medpace Holdings' Price Target to $273 From $252, Keeps Buy Rating	23-07-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Medpace Holdings, Inc.

Equities

MEDP

US58506Q1094

Analyst Reco.

Filters